Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Treatment of hyperphosphatemia associated with chronic renal insufficiency in patients undergoing dialysis (haemodialysis, peritoneal dialysis) Age: Adult Condition: Initial treatment |
Dose: Oral Tablet – 1 tablet Frequency: three times daily Note: Adjusted according to serum-phosphate concentration |
|
Indication: Treatment of hyperphosphatemia associated with chronic renal insufficiency in patients undergoing dialysis (haemodialysis, peritoneal dialysis) Age: Adult Condition: Maintenance treatment |
Dose: Oral Tablet – 3–10 tablets Frequency: daily Note: Maximum 12 tablets per day |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: No approved pediatric dosage available Note: No approved pediatric dosage available |
Administration
- Must be taken with meals
- Do not chew tablets
Side Effect
- Soft stools
- gastrointestinal irritation like nausea
- anorexia
- sensation of fullness
- belching and constipation
- diarrhoea
- Hypercalcaemia either asymptomatic or symptomatic
- asymptomatic hypermagnesaemia
- Moderate to severe symptomatic hypercalcaemia
- symptomatic hypermagnesaemia
- Hyperkalaemia
- magnesium-induced osteal mineralisation disturbances
- For symptoms of hypercalcaemia and hypermagnesaemia
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Nitrofurantoin
|
May decrease bioavailability and anti-infective effect
|
|
Antibiotics (tetracyclines, doxycycline, norfloxacin, some Cephalosporins (Cephalothin, Cefazolin, Cefadroxil, Cefuroxime, Ceftriaxone, Cefotaxime), some quinolones)
|
Affects absorption
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general drug reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.